COVID-19 Bill and Melinda Gates Foundation
We are joining the COVID-19 Therapeutics Accelerator of the Bill and Melinda Gates Foundation to fight the pandemic. Click here to learn more.
Search
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
A beginner’s guide to fighting off cat parasites
Prof. Donato Traversa explains the risk of multiparasitic infections and/or infestations in cats. Click here to read and find out more information.
COVID-19 Boehringer Ingelheim Thailand equips frontline
Boehringer Ingelheim Thailand is working together with the Thai Department of Disease Control during the pandemic. Click here to learn more.
Different life stages dogs preventive health
As a dog owner you know that dogs are special, but what does your dog need to thrive at every age? Click here to find out and get some tips!
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Our Health and Safety initiative - BE SAFE
We strive to keep our employees in good health, supporting their well-being across all working environments. Learn about our BE SAFE initiative.
Benefits of Pradaxa®
Here you can find a discussion of the benefits offered by Pradaxa® for stroke prevention in patients with atrial fibrillation. Click here to learn more.
History of Cats
Since the beginning of human civilisation, cats have been companions to people. Click here to learn more about the history of cats with humans.
Life stages of cats
Owners are often unaware of the changing health of their cats as they age. Click here to learn more about cats' changing medical needs as they age.
COVID-19 Social distancing and pet care - A vet gives advice
We have asked Karsten Hesse, Technical Service Manager Pet at Boehringer Ingelheim from Germany, about the topic of social distancing and pet care.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.
COVID-19 Learning from the pandemic
Online training options develop vets and other animal health professionals’ skills helping them overcome movement restrictions to thrive around the globe.
Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives. Find out more about our partnering culture.
Coronavirus in pets and humans: learn the differences
Coronavirus in pets and humans: learn the differences. To date, there is no evidence that dogs and cats can be infected or transmit COVID-19.
Patient Voices...Ian's Story
Watch the video to find out more about how Ian manages AF in his day to day life. Ian discusses the importance of educating yourself and more.
Expectations towards our business partners
Boehringer Ingelheim utilises an extensive network of international suppliers. Click here to learn more about our expectations towards our suppliers.
Introducing Karl and Klara Kidney
Kidney disease and type 2 diabetes are closely linked, and share many of the same risk factors and pathological pathways. Click here to find out more.
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.
Professor Baumgart
After being diagnosed with diabetes, Eric’s unique bonds with Peetey and Jake meant they could run miles across the Idaho wilderness. Learn more here.
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
Interview: Excellence in stem cell treatments
Acquisition of GST reflects the enormous potential of biotechnology research to provide breakthrough therapies for major diseases. Learn more.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
Webinars for clinicians on needs of vulnerable respiratory
Webinars with more than 1,000 HCPs to provide an update on prevention and treatment recommendations for vulnerable respiratory patients. Learn more here.
COVID-19 India - supporting community during the pandemic
Boehringer Ingelheim India was amongst the first few companies supporting local authorities in Maharashtra in this crisis. Click here to learn more.